Total Payments
$4,964
2024 Payments
$222.02
Companies
40
Transactions
301
Medicare Patients
6,088
Medicare Billing
$648,976
Payment Breakdown by Category
Food & Beverage$4,840 (97.5%)
Education$124.80 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,840 | 293 | 97.5% |
| Education | $124.80 | 8 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $626.46 | 37 | $0 (2023) |
| ABBVIE INC. | $560.62 | 32 | $0 (2024) |
| Amgen Inc. | $499.15 | 35 | $0 (2023) |
| GlaxoSmithKline, LLC. | $444.90 | 24 | $0 (2023) |
| Novo Nordisk Inc | $286.22 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $277.68 | 17 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $271.47 | 22 | $0 (2023) |
| PFIZER INC. | $256.39 | 15 | $0 (2023) |
| Astellas Pharma US Inc | $190.14 | 10 | $0 (2024) |
| Lilly USA, LLC | $180.66 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.02 | 9 | Novo Nordisk Inc ($47.11) |
| 2023 | $470.97 | 23 | Amgen Inc. ($65.28) |
| 2022 | $628.24 | 36 | ABBVIE INC. ($176.20) |
| 2021 | $836.81 | 46 | AbbVie Inc. ($267.05) |
| 2020 | $422.62 | 21 | AstraZeneca Pharmaceuticals LP ($113.64) |
| 2019 | $716.33 | 48 | Novartis Pharmaceuticals Corporation ($262.56) |
| 2018 | $879.16 | 66 | Novartis Pharmaceuticals Corporation ($158.90) |
| 2017 | $788.21 | 52 | GlaxoSmithKline, LLC. ($149.00) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $40.42 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Biological | ||||||
| 09/10/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $15.77 | General |
| Category: Medical Device | ||||||
| 07/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Obesity | ||||||
| 05/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Obesity | ||||||
| 03/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Biological | ||||||
| 03/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
| 12/27/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Neuromodulation | ||||||
| 12/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/05/2023 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Vaccines | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 09/18/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/05/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/31/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Bone Health | ||||||
| 08/30/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Inflammation | ||||||
| 08/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $22.18 | General |
| 06/23/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,683 | 2,888 | $647,008 | $189,735 |
| 2022 | 22 | 1,340 | 2,088 | $486,795 | $150,105 |
| 2021 | 26 | 1,472 | 2,431 | $535,424 | $155,362 |
| 2020 | 26 | 1,593 | 2,464 | $517,649 | $153,774 |
Total Patients
6,088
Total Services
9,871
Medicare Billing
$648,976
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 513 | $148,760 | $46,256 | 31.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 107 | 261 | $64,053 | $20,967 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 277 | $55,807 | $19,614 | 35.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 113 | 125 | $54,342 | $18,914 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $32,929 | $17,309 | 52.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 117 | $84,006 | $11,468 | 13.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 135 | 152 | $29,333 | $10,203 | 34.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 138 | 152 | $30,093 | $9,483 | 31.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 142 | 159 | $19,342 | $7,193 | 37.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 33 | $45,837 | $4,605 | 10.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $6,580 | $3,364 | 51.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 60 | 84 | $7,850 | $2,923 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,682 | $2,662 | 34.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 25 | 25 | $7,391 | $2,643 | 35.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 25 | 43 | $5,924 | $2,375 | 40.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 22 | $16,214 | $2,092 | 12.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $2,860 | $1,647 | 57.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 27 | 31 | $4,720 | $1,548 | 32.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 27 | $3,515 | $1,222 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 126 | $1,890 | $1,058 | 56.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $7,560 | $1,009 | 13.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 20 | 84 | $1,083 | $512.35 | 47.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 34 | 367 | $7,516 | $284.32 | 3.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 22 | $1,258 | $258.72 | 20.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $464.04 | $124.80 | 26.9% |
About Dr. Sam Baroudi, MD
Dr. Sam Baroudi, MD is a Internal Medicine healthcare provider based in Vista, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316936933.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Baroudi, MD has received a total of $4,964 in payments from pharmaceutical and medical device companies, with $222.02 received in 2024. These payments were reported across 301 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($4,840).
As a Medicare-enrolled provider, Baroudi has provided services to 6,088 Medicare beneficiaries, totaling 9,871 services with total Medicare billing of $648,976. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Vista, CA
- Active Since 10/17/2005
- Last Updated 09/15/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316936933
Products in Payments
- ENTRESTO (Drug) $561.40
- FARXIGA (Drug) $262.32
- UBRELVY (Drug) $243.66
- XARELTO (Drug) $215.26
- VRAYLAR (Drug) $204.81
- ELIQUIS (Drug) $178.36
- Aimovig (Biological) $167.54
- EVENITY (Biological) $163.40
- ANORO (Drug) $146.10
- TRELEGY ELLIPTA (Drug) $144.86
- Ozempic (Drug) $110.95
- LONHALA MAGNAIR (Drug) $102.22
- Myrbetriq (Drug) $91.70
- NUEDEXTA (Drug) $83.30
- QULIPTA (Drug) $76.23
- MOUNJARO (Drug) $71.20
- AUSTEDO (Drug) $70.72
- LEQVIO (Drug) $65.06
- Dayvigo (Drug) $62.91
- Kerendia (Drug) $61.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Vista
Dr. Hanh Bui, M.d, M.D
Internal Medicine — Payments: $19,344
Internal Medicine $19,344
Dr. Xiangli Li, M.d. Ph.d., Pc, M.D. PH.D., PC
Internal Medicine — Payments: $10,318
Internal Medicine $10,318
Mr. Alexander Delgadillo, M.d, M.D
Internal Medicine — Payments: $7,113
Internal Medicine $7,113
Dr. Franklin Galef, Md, MD
Internal Medicine — Payments: $5,518
Internal Medicine $5,518
Dr. Morris Wisniewski, M.d, M.D
Internal Medicine — Payments: $4,840
Internal Medicine $4,840
Dr. Sanjana Chaturvedi, Md, MD
Internal Medicine — Payments: $4,689
Internal Medicine $4,689